Global value chains and Turkish foreign trade
2022
0 views
0 downloads
Advisor: Prof. Dr. Turan Yay
Abstract (EN)
Turkey has experienced significant globalization through foreign trade since the 1980s. The globalization of trade is important in terms of economic developments in Turkey. In this context, the role and importance of the global value chain, which is one of the most popular concepts of recent years, in Turkish foreign trade is the central hypothesis of the study. In this study, the participation of Turkey and the BRIC countries in the global value chain has been calculated. Within the framework of the evaluation of the relevant literature and empirical calculations, we can say that although these countries have structural and historical differences, Turkey's participation in the global value chain converges with the values of the BRIC countries. However, since the 1980s, Turkey, with its structural current account deficit problem, has differed from these countries. In addition, according to our regression analysis, Turkey's increase in foreign trade participation positively affects GDP growth regardless of imports and exports.
Author
Nur Akmanlar
Institution
How to Cite
Nur Akmanlar (Master Thesis). Global value chains and Turkish foreign trade, 2022, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)